Disc Medicine (IRON) Income towards Parent Company (2020 - 2026)

Disc Medicine (IRON) has 7 years of Income towards Parent Company data on file, last reported at -$63.6 million in Q1 2026.

• On a quarterly basis, Income towards Parent Company fell 87.11% year-over-year to -$63.6 million in Q1 2026; TTM through Mar 2026 was -$196.8 million, a 68.81% decrease from a year earlier, with the FY2025 full-year figure at -$167.3 million, down 53.02% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$63.6 million, down from -$15.7 million in the prior quarter.
• Over the last five years, Income towards Parent Company for IRON reached as high as -$9.6 million in Q2 2022 and fell as low as -$63.6 million in Q1 2026.
• Historically, Income towards Parent Company has averaged -$27.3 million across 5 years, with a median of -$23.5 million in 2023.
• Across the five-year window, Income towards Parent Company sank 155.96% in 2022 and surged 47.07% in 2025, its largest moves.
• Year by year, Income towards Parent Company stood at -$11.2 million in 2022, then slumped by 109.41% to -$23.5 million in 2023, then decreased by 25.86% to -$29.6 million in 2024, then jumped by 47.07% to -$15.7 million in 2025, then slumped by 305.13% to -$63.6 million in 2026.
• Per Business Quant data, the three most recent Income towards Parent Company figures were -$63.6 million in Q1 2026, -$15.7 million in Q4 2025, and -$62.3 million in Q3 2025.